Start › Nowotwór przerzutowy › Georgia › Atlanta
Badania kliniczne dla Nowotwór przerzutowy w mieście Atlanta, GA
28 badań dla Nowotwór przerzutowy szuka uczestników w ośrodkach w mieście Atlanta i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RekrutacjaFaza 3
- Piedmont Cancer Institute, Atlanta
- Piedmont Healthcare, Atlanta
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Winship Cancer Institute of Emory University, Atlanta
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekrutacjaFaza 1
- Emory University, Atlanta
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekrutacjaFaza 1
- Emory Winship Cancer Institute, Atlanta
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RekrutacjaFaza 1/2
- Children's Healthcare of Atlanta - Egleston Hospital, Atlanta
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
RekrutacjaFaza 1
- Emory Winship Cancer Institute, Atlanta
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekrutacjaFaza 1
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekrutacjaFaza 3
- Winship Cancer Institute, Emory University, Atlanta
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekrutacjaFaza 3
- Emory University School of Medicine- Grady Campus, Atlanta
- Winship Cancer Institute, Emory University, Atlanta
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
RekrutacjaFaza 1
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekrutacjaFaza 1/2
- Avenzo Therapeutics Recruiting Site, Atlanta
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekrutacjaFaza 3
- Winship Cancer Institute of Emory University, Atlanta
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
RekrutacjaFaza 2
- Emory University School of Medicine, Atlanta
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekrutacjaFaza 1
- Emory University Hospital, Atlanta
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RekrutacjaFaza 1/2
- Crinetics Study Site, Atlanta
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- Winship Cancer Center - Emory University, Atlanta
A Study of PYX-201 in Advanced Solid Tumors
RekrutacjaFaza 1
- Winship Cancer Institute, Emory University, Atlanta
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
RekrutacjaFaza 1/2
- Winship Cancer Institute, Emory University, Atlanta
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekrutacjaFaza 1
- Winship Cancer Institute at Emory University, Atlanta
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekrutacjaFaza 1/2
- Piedmont Healthcare, Atlanta
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RekrutacjaFaza 3
- Emory University, Atlanta
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekrutacjaFaza 2/3
- Emory Winship Cancer Institute, Atlanta
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RekrutacjaFaza 1/2
- Emory Winship Cancer Institute, Atlanta
Venetoclax Basket Trial for High Risk Hematologic Malignancies
RekrutacjaFaza 1
- Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
RekrutacjaFaza 3
- Emory Winship Cancer Institute, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekrutacjaBadanie obserwacyjne
- Massive Bio SYNERGY-AI site, Atlanta
Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
RekrutacjaWczesna faza 1
- Emory University Hospital/Winship Cancer Institute, Atlanta
A Beta-only IL-2 ImmunoTherapY Study
RekrutacjaFaza 1/2
- Emory - Winship Cancer Institute, Atlanta
Badania dla Nowotwór przerzutowy w innych miastach
- Houston, TX104 badań
- New York City, NY93 badań
- Nashville, TN70 badań
- Boston, MA63 badań
- Los Angeles, CA57 badań
- St. Louis, MO54 badań
- Arlington, VA53 badań
- Philadelphia, PA46 badań
- Chicago, IL45 badań
- San Antonio, TX44 badań
- Washington, DC43 badań
- Dallas, TX42 badań
Inne badania w mieście Atlanta
- Nowotwory (wszystkie typy)49 badań
- Niedrobnokomórkowy rak płuca47 badań
- Szpiczak mnogi42 badań
- Rak piersi41 badań
- Rak prostaty33 badań
- Ostra białaczka szpikowa31 badań
- Rak jajnika29 badań
- Rak jelita grubego i odbytnicy29 badań
- Rak płuc29 badań
- Duża depresja25 badań
- Niewydolność serca25 badań
- Rak płaskonabłonkowy głowy i szyi24 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.